As COVID-19 is possibly moving toward becoming endemic, diagnostic testing and monitoring of SARS-CoV-2 genetic changes will continue to play critical roles in disease control strategies.
In this convenient e-book, we’ve collected a series of recent blogs* which outline how Thermo Fisher’s COVID-19 testing and SARS-CoV-2 surveillance technologies remain reliable in the face of a dynamic pathogen, including an explanation of the S gene advantage that is helping to identify variant trends.
*This e-book was created using a series of recently published blogs that were each accurate and current at the original time of original publication.